The pace of the growth is putting a premium on logistics capabilities, including distribution centers positioned to quickly reach U.S. customers.

Acquiring Roundup as part of the deal to take over Monsanto has embroiled Bayer in costly litigation over allegations the weedkiller causes cancer, a charge the company denies.

Lilly is looking to double its capacity to make drugs that mimic incretin, a hormone that gives the sensation of having eaten, by the end of the year.

CVS’s drugstore chain is coping with headwinds that include diminished concerns about the pandemic, which has translated into fewer visits for COVID-19 tests and vaccinations.

The country has so far relied almost solely on homegrown medicines and vaccines to shore up immunity and treat COVID patients. 

With its new financing, TransVoyant will scale to reach new customers and expand its platform’s use cases.

The shortages are a reminder that volatile turns in demand and supply that have marked the pandemic are still undercutting some sectors.

Though the vast majority of the country’s population has already been vaccinated, Chinese authorities have relied on locally developed shots like those from state-backed Sinopharm and Sinovac.